Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Goldblum

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|October 22, 2008
Primary treatment of nasolacrimal duct obstruction with balloon catheter dilation in children younger than 4 years of age, Michael X Repka, B Michele Melia, et al.
ACS Chemical Biology|July 15, 2014
Toxicity modulation, resistance enzyme evasion, and A-site X-ray structure of broad-spectrum antibacterial neomycin analogsJuan Pablo Maianti, Hiroki Kanazawa, Paola Dozzo, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Toward Overcoming Staphylococcus aureus Aminoglycoside Resistance Mechanisms with a Functionally Designed Neomycin AnalogueStephen Hanessian, Alexandre Giguère, Justyna Grzyb, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2012
Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: clinical compound TD-2749Daniel D Long, Scott R Armstrong, David T Beattie, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
Synthesis and spectrum of the neoglycoside ACHN-490James B Aggen, Eliana S Armstrong, Adam A Goldblum, et al.
Chemmedchem|September 8, 2017
Synthesis and Microbiological Evaluation of Novel Tetracyclic FluoroquinolonesAllan S Wagman, Ryan Cirz, Glenn McEnroe, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2012
Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipationDaniel D Long, Scott R Armstrong, David T Beattie, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|October 22, 2008
Primary treatment of nasolacrimal duct obstruction with balloon catheter dilation in children younger than 4 years of age, Michael X Repka, B Michele Melia, et al.
ACS Chemical Biology|July 15, 2014
Toxicity modulation, resistance enzyme evasion, and A-site X-ray structure of broad-spectrum antibacterial neomycin analogsJuan Pablo Maianti, Hiroki Kanazawa, Paola Dozzo, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Toward Overcoming Staphylococcus aureus Aminoglycoside Resistance Mechanisms with a Functionally Designed Neomycin AnalogueStephen Hanessian, Alexandre Giguère, Justyna Grzyb, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2012
Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: clinical compound TD-2749Daniel D Long, Scott R Armstrong, David T Beattie, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
Synthesis and spectrum of the neoglycoside ACHN-490James B Aggen, Eliana S Armstrong, Adam A Goldblum, et al.
Chemmedchem|September 8, 2017
Synthesis and Microbiological Evaluation of Novel Tetracyclic FluoroquinolonesAllan S Wagman, Ryan Cirz, Glenn McEnroe, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2012
Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipationDaniel D Long, Scott R Armstrong, David T Beattie, et al.
Pageof 3